Precursor Ventures is a team-first pre-seed and seed investor that writes first institutional checks into North American startups, with a broader geographic exception in fintech. The firm is intentionally sector-agnostic across software, hardware, and select consumer businesses, but avoids biotech, life sciences, and later-stage rounds, preferring to back founders before product or revenue exists.
Precursor’s evaluation framework is fundamentally team‑first, followed by market and then product. Internally the firm weights roughly 70 % founder quality and 30 % market attractiveness, requiring the market to be at least “not hated.” Traction is not a prerequisite; the firm often invests in the “no‑data” quadrant where both business and founder information are scarce, giving it a competitive edge. Decision‑makers look for durable, non‑obvious advantages in business model or market segmentation, and they apply a mental scorecard asking if the company could reach $100 M ARR in seven years with healthy margins. Deal‑breakers include conflicts with existing portfolio companies, entry at Series A, and investments in biotech or capital‑intensive businesses without a clear technology angle. Typical deals are pre‑seed or seed rounds ≤$5 M, with initial checks of $250‑$500 K, and the firm keeps reserves for follow‑on support.
See the rest of how Precursor Ventures decides.
Evaluation framework, investment themes, pitch guidance and the partner map. One email, no password — we send a link and you land right back here.